Pursennid



Indications and Reactions:

Role Indications Reactions
Primary
Constipation 39.1%
Dyschezia 15.0%
Drug Abuse 7.5%
Hypertension 6.0%
Cancer Pain 4.5%
Insomnia 3.8%
Diabetes Mellitus 3.0%
Gastric Cancer 3.0%
Eczema 2.3%
Gastritis 2.3%
Hyperlipidaemia 2.3%
Neurosis 2.3%
Astringent Therapy 1.5%
Barium Swallow 1.5%
Lumbar Hernia 1.5%
Prostatitis 1.5%
Benign Prostatic Hyperplasia 0.8%
Depression 0.8%
Duodenal Ulcer 0.8%
Dysuria 0.8%
Vomiting 11.4%
Ileus 8.6%
Rash 8.6%
Abdominal Pain 5.7%
Hepatic Function Abnormal 5.7%
Hyperprolactinaemia 5.7%
Hypokalaemia 5.7%
Hyponatraemia 5.7%
Incorrect Drug Administration Duration 5.7%
Melaena 5.7%
Syncope 5.7%
Abdominal Distension 2.9%
Blood Potassium Decreased 2.9%
Blood Pressure Increased 2.9%
Blood Uric Acid Increased 2.9%
Body Temperature Decreased 2.9%
Cardiovascular Disorder 2.9%
Chromaturia 2.9%
Diarrhoea 2.9%
Diverticulum Intestinal Haemorrhagic 2.9%
Secondary
Constipation 19.7%
Hypertension 9.3%
Drug Use For Unknown Indication 8.5%
Hyperphosphataemia 7.2%
Insomnia 6.4%
Product Used For Unknown Indication 6.4%
Myelodysplastic Syndrome 4.8%
Lumbar Spinal Stenosis 4.3%
Cardiac Failure 4.0%
Ileus 4.0%
Schizophrenia, Paranoid Type 4.0%
Drug Abuse 3.2%
Cardiovascular Disorder 2.7%
Cancer Pain 2.4%
Diabetes Mellitus 2.4%
Colon Cancer 2.1%
Depression 2.1%
Hyperkalaemia 2.1%
Hyperuricaemia 2.1%
Pain 2.1%
Loss Of Consciousness 9.5%
Vitreous Floaters 9.5%
Large Intestine Perforation 7.9%
Respiratory Failure 7.9%
Agranulocytosis 6.3%
Somnolence 6.3%
Vomiting 6.3%
Cerebral Infarction 4.8%
Hallucination 4.8%
Hepatic Function Abnormal 4.8%
Hyperammonaemia 4.8%
Vasculitis 4.8%
Colitis Ischaemic 3.2%
Fatigue 3.2%
Pemphigus 3.2%
Pneumonia 3.2%
Renal Failure Chronic 3.2%
Swelling 3.2%
Alopecia 1.6%
Blood Potassium Decreased 1.6%
Concomitant
Constipation 16.2%
Prophylaxis 13.5%
Product Used For Unknown Indication 11.5%
Hypertension 9.8%
Drug Use For Unknown Indication 7.6%
Rheumatoid Arthritis 5.2%
Insomnia 5.1%
Pain 5.0%
Cancer Pain 3.6%
Diabetes Mellitus 3.0%
Renal Cell Carcinoma 2.6%
Gastritis 2.5%
Multiple Myeloma 2.5%
Schizophrenia 2.2%
Parkinson's Disease 1.8%
Depression 1.7%
Metastatic Renal Cell Carcinoma 1.7%
Nausea 1.6%
Hyperlipidaemia 1.5%
Angina Pectoris 1.5%
White Blood Cell Count Decreased 14.0%
Vomiting 8.3%
Platelet Count Decreased 7.7%
Interstitial Lung Disease 7.6%
Pyrexia 6.5%
Rhabdomyolysis 5.7%
Somnolence 5.4%
Rash 5.3%
Pneumonia 5.2%
Renal Impairment 3.5%
Pleural Effusion 3.4%
White Blood Cell Count Increased 3.4%
Hepatic Function Abnormal 3.3%
Malaise 3.1%
Thrombocytopenia 3.1%
Pneumocystis Jiroveci Pneumonia 3.0%
Sepsis 3.0%
Stomatitis 3.0%
Nausea 2.6%
Tremor 2.6%
Interacting
Product Used For Unknown Indication 95.0%
Onychomycosis 5.0%
Dementia 100.0%